Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1 beta levels


Yalcin A. D. , ÇİLLİ A., Bisgin A. , Strauss L. G. , Herth F.

EXPERT OPINION ON BIOLOGICAL THERAPY, cilt.13, ss.1335-1341, 2013 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 13 Konu: 9
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1517/14712598.2013.819338
  • Dergi Adı: EXPERT OPINION ON BIOLOGICAL THERAPY
  • Sayfa Sayıları: ss.1335-1341

Özet

Background: There have been concerns about the cardiovascular safety of omalizumab.